Nanobiomaterials and Nanomedicines for Metabolic Disorders
- 1st Edition - December 1, 2025
- Latest edition
- Editors: Subhash C. Mandal, Nilanjan Ghosh, Amit Kumar Halder
- Language: English
Nanobiomaterials and Nanomedicines for Metabolic Disorders delves into the transformative role of nanotechnology in addressing metabolic disorders. The book begins with an overvi… Read more
Nanobiomaterials and Nanomedicines for Metabolic Disorders delves into the transformative role of nanotechnology in addressing metabolic disorders. The book begins with an overview of nanoparticle classifications and then explores the synthesis of biomaterials and drug delivery systems. In addition, it explores innovative diagnostic and imaging techniques while presenting cutting-edge therapeutic approaches. Later chapters focus on specific metabolic disorders, such as cardiovascular and lifestyle-related conditions. The book is tailored to researchers, students, and healthcare professionals seeking advanced theranostic approaches to these disorders. By bridging nanotechnology with metabolic pathways, the text offers insights into how targeted nanomedicines can improve therapeutic outcomes.
- Utilizes an interdisciplinary approach, bridging the fields of materials science and biomedical science to improve translational efficiency
- Covers a range of nanoparticles and nanotechnologies for the diagnosis and treatment of metabolic disorders, aiding readers to select the most suitable for their work
- Details various metabolic pathways and disorders, including glycogen and lysosomal storage, type 2 diabetes, obesity, and metabolic vascular disorders
Researchers and postgraduate students in the fields of materials science, nanotechnology, endocrinology, and pharmaceutical science with an interest the development of novel treatment strategies for metabolic disorders
Section I: Nanomedicines for metabolic disorders: drug delivery
1. Clinical use of inorganic and organic nanoparticles in metabolic syndromes
2. Application of nanomedicines in mitigating oxidative stress
3. Nanomedicines to enhance oral bioavailability for metabolic disorders
4. Nanotechnology for the therapeutic use of biologics to treat metabolic disorders
Section II: Nanotechnology in metabolic disorders: diagnosis and therapy
5. Application of quantum dots in metabolic disorders
6. Medical imaging using nanotechnology
7. Nanorobotics: applications in metabolic disorders
8. Nanomaterials for three-dimensional printing in management of metabolic disorders
Section III: Nanomedicines for lifestyle metabolic disorders
9. Nanomedicines to alleviate hepatic metabolic disorders
10. Role of nanomedicines in type 2 diabetes
11. Nanomedicines for precise therapy in hyperlipidaemia & obesity
Section IV: Nanomedicines for cellular metabolic disorders
12. Application of nanotechnology in lysosomal storage diseases
13. Nanotechnology to target autophagy-mediated metabolic disorders
14. Application of nanomedicines in glycogen storage diseases
Section V: Nanomedicines for metabolic cardiovascular diseases
15. Nanotechnology for metabolic vascular diseases
16. Nanomedicines for the management of atherosclerosis
1. Clinical use of inorganic and organic nanoparticles in metabolic syndromes
2. Application of nanomedicines in mitigating oxidative stress
3. Nanomedicines to enhance oral bioavailability for metabolic disorders
4. Nanotechnology for the therapeutic use of biologics to treat metabolic disorders
Section II: Nanotechnology in metabolic disorders: diagnosis and therapy
5. Application of quantum dots in metabolic disorders
6. Medical imaging using nanotechnology
7. Nanorobotics: applications in metabolic disorders
8. Nanomaterials for three-dimensional printing in management of metabolic disorders
Section III: Nanomedicines for lifestyle metabolic disorders
9. Nanomedicines to alleviate hepatic metabolic disorders
10. Role of nanomedicines in type 2 diabetes
11. Nanomedicines for precise therapy in hyperlipidaemia & obesity
Section IV: Nanomedicines for cellular metabolic disorders
12. Application of nanotechnology in lysosomal storage diseases
13. Nanotechnology to target autophagy-mediated metabolic disorders
14. Application of nanomedicines in glycogen storage diseases
Section V: Nanomedicines for metabolic cardiovascular diseases
15. Nanotechnology for metabolic vascular diseases
16. Nanomedicines for the management of atherosclerosis
- Edition: 1
- Latest edition
- Published: December 1, 2025
- Language: English
SM
Subhash C. Mandal
Dr. Subhash C. Mandal, PhD is Professor at Division of Pharmacognosy, Department of Pharmaceutical Technology, Jadavpur University, Kolkata, India. Professor Mandal is the recipient of prestigious awards including Endeavour Research Award, Government of Australia; Distinguished Education & Research Award, AAiPS, USA; Talented Scientist Award, University of Colombo, Sri Lanka; SAARC Fellowship Award, University Grants Commission (UGC), Bangladesh; Fast Track Young Scientist Award, Department of Science and Technology , UGC Research Award, India and Outstanding University Teachers’ Award , Department of higher education , Government of West Bengal , India. He has supervised more than 30 doctoral and 25 M. Pharm scholars and has more than 300 research publications, several patents, books and book chapters to his credit. Professor Mandal has delivered more than 50 research presentations around the globe, has chaired many international conferences, and successfully completed more than 10 government-funded research projects. He is reviewer and board member of several high-impact journals and is a recognized host scientist for many international research programs with developing countries sponsored by the Indian Government. He has visited more than 30 countries for various scientific deliberations, collaborations and exchange programmes.
Affiliations and expertise
Professor, Division of Pharmacognosy, Department of Pharmaceutical Technology, Jadavpur University, Kolkota, IndiaNG
Nilanjan Ghosh
Dr. Nilanjan Ghosh is working as an Assistant Professor in the Department of Pharmaceutical Technology, Jadavpur University, Kolkata, India. He has completed his M Pharm from BHU (2008) and PhD from Jadavpur University (2017), India. He is serving as an academician for last 13 years. His research interest involves drug discovery for metabolic and inflammation related disorders. He has supervised more than 10 M.Pharm scholars and has more than 15 research publications, and 6 book chapters to his credit. He is reviewer and board member of several high-impact journals.
Affiliations and expertise
Assistant Professor, Department of Pharmaceutical Technology, Jadavpur University, Kolkata, IndiaAH
Amit Kumar Halder
Dr. Amit Kumar Halder is an Associate Professor at the Dr. B.C. Roy College of Pharmacy and Allied Health Sciences, West Bengal, India. He is also Joint Division-in-Charge in the Division of Pharmaceutical Chemistry at the same institute. He received his Ph.D. in Pharmacy from Jadavpur University, India, in 2016. He has five years of teaching experience and five years of postdoctoral experience. He worked as a postdoctoral researcher in University of Kwazulu-Natal, South Africa for one year and in University of Porto, Portugal, for four years. His specialization is computational chemistry, synthetic medicinal chemistry and cancer biology. He has published 58 articles in international journals and four book chapters.
Affiliations and expertise
Associate Professor, Dr. B.C. Roy College of Pharmacy and Allied Health Sciences, West Bengal, India